We are live on ! Find out more
LAB icon

Standard BioTools
LAB

112 hedge funds and large institutions have $249M invested in Standard BioTools in 2020 Q2 according to their latest regulatory filings, with 30 funds opening new positions, 36 increasing their positions, 40 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

269% more call options, than puts

Call options by funds: $468K | Put options by funds: $127K

53% more capital invested

Capital invested by funds: $163M → $249M (+$86.6M)

50% more first-time investments, than exits

New positions opened: 30 | Existing positions closed: 20

9% more funds holding

Funds holding: 103 → 112 (+9)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

3.08% less ownership

Funds ownership: 91.05% → 87.97% (-3.1%)

10% less repeat investments, than reductions

Existing positions increased: 36 | Existing positions reduced: 40

Holders
112
Holders Change
+9
Holders Change %
+8.74%
% of All Funds
2.3%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
30
Increased
36
Reduced
40
Closed
20
Calls
$468K
Puts
$127K
Net Calls
+$341K
Net Calls Change
+$319K

Top Buyers

Rank Fund Capital Flow
1
O
OrbiMed
New York
+$10.1M
2
TM
Tikvah Management
North Carolina
+$4.35M
3
Millennium Management
Millennium Management
New York
+$3.37M
4
PVI
Pura Vida Investments
New York
+$2.94M
5
UBS Group
UBS Group
Switzerland
+$2.79M

Top Sellers

Rank Fund Capital Flow
1
Russell Investments Group
Russell Investments Group
United Kingdom
-$20.3M
2
EIP
Easterly Investment Partners
Massachusetts
-$12.4M
3
Mitsubishi UFJ Trust & Banking
Mitsubishi UFJ Trust & Banking
Japan
-$2.78M
4
PHS
PFM Health Sciences
California
-$2.61M
5
Vanguard Group
Vanguard Group
Pennsylvania
-$1.84M
Name Holding Trade Value Shares
Change 		Change in
Stake
Norges Bank
26
Norges Bank
Norway
$2.59M – – –
Two Sigma Investments
27
Two Sigma Investments
New York
$2.52M +$556K +159,663 +34%
NIM
28
Needham Investment Management
New York
$2.26M +$1.96M +562,500 New
Bank of New York Mellon
29
Bank of New York Mellon
New York
$1.99M -$185K -53,221 -10%
GIM
30
Granahan Investment Management
Massachusetts
$1.9M -$939K -269,745 -36%
EP
31
Eversept Partners
New York
$1.88M +$1.63M +467,923 New
Dimensional Fund Advisors
32
Dimensional Fund Advisors
Texas
$1.75M +$391K +112,245 +35%
Jacobs Levy Equity Management
33
Jacobs Levy Equity Management
New Jersey
$1.69M +$145K +41,748 +11%
Point72 Asset Management
34
Point72 Asset Management
Connecticut
$1.6M +$1.39M +399,415 New
Alyeska Investment Group
35
Alyeska Investment Group
Illinois
$1.37M +$1.19M +341,605 New
PAM
36
Panagora Asset Management
Massachusetts
$1.28M -$342K -98,244 -23%
AQR Capital Management
37
AQR Capital Management
Connecticut
$1.16M +$140K +40,267 +16%
DCM
38
DG Capital Management
New York
$938K +$815K +233,887 New
LCS
39
Levin Capital Strategies
New York
$760K +$93.6K +26,878 +17%
AC
40
Alexandria Capital
Virginia
$757K – – –
Charles Schwab
41
Charles Schwab
California
$692K +$21.2K +6,091 +4%
Deutsche Bank
42
Deutsche Bank
Germany
$671K +$400K +114,988 +220%
SEI Investments
43
SEI Investments
Pennsylvania
$659K +$2.42K +694 +0.4%
QI
44
QS Investors
New York
$641K -$5.22K -1,500 -0.9%
California Public Employees Retirement System
45
California Public Employees Retirement System
California
$626K +$72.2K +20,729 +15%
IP
46
Intellectus Partners
California
$514K – – –
Squarepoint
47
Squarepoint
New York
$507K +$381K +109,351 +640%
Connor, Clark & Lunn Investment Management (CC&L)
48
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$490K -$109K -31,283 -20%
AllianceBernstein
49
AllianceBernstein
Tennessee
$482K +$106K +30,400 +34%
Morgan Stanley
50
Morgan Stanley
New York
$481K +$396K +113,748 +1,753%
1
2
3 4 5

LAB Hedge Fund Activity: Q2 2020 in Review

112 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Standard BioTools (LAB) for Q2 2020, worth a combined $249M — up 53% from $163M a quarter earlier.

Buyers outnumbered sellers: 30 funds opened new LAB positions and 20 closed out — a net gain of 10 holders — while 36 added to existing stakes and 40 trimmed.

The largest buyer was OrbiMed, opening a new position worth an estimated $10.1M. The largest seller was Russell Investments Group, cutting an estimated $20.3M.

  • 112 institutional investors held Standard BioTools (LAB) as of Q2 2020, up from 103 in Q1 2020.
  • Funds reported $249M of Standard BioTools stock for Q2 2020, up 53% quarter-over-quarter.
  • 30 funds opened new Standard BioTools positions in Q2 2020 and 20 closed out, a net change of +10 holders.
  • The largest Standard BioTools buyer in Q2 2020 was OrbiMed, an estimated $10.1M added.
  • The largest Standard BioTools seller in Q2 2020 was Russell Investments Group, an estimated $20.3M sold.

Based on aggregated 13F filings for Q2 2020.